MedPage Today September 18, 2023
Judy George

— Privacy policies, terms of sale often are unclear

Direct-to-consumer (DTC) laboratory tests — for the thyroid, hormonal biomarkers, or diabetes and hemoglobin A1c, for example — often had unclear terms of sale and vague privacy policies, a qualitative study showed.

Of 21 U.S. companies that offered DTC lab tests, less than half declared compliance with the Health Insurance Portability and Accountability Act (HIPAA), and less than a quarter specified protections for biological samples, according to Louiza Kalokairinou, PhD, of the Baylor College of Medicine Center for Medical Ethics and Health Policy in Houston, and co-authors.

More than half stated consumer data potentially could be used for research purposes, either internally or through a third party, Kalokairinou and colleagues reported...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Healthcare System, HIPAA, Patient / Consumer, Privacy / Security, Provider
The Benefits of Receiving Care in the Comfort of Your Own Home
7 States Passed Abortion Rights Ballot Measures. But Changes Won’t be Like a “Light Switch,” Experts Say
Revolutionizing Breast Cancer Survivorship Care: Early Detection and Prevention of Lymphedema
Women Are Deprioritizing Their Healthcare Needs: New Research
What You Should Know About Ovarian Cancer Vaccines

Share This Article